Table 2.
Outcome data for 126 trial participants at 12 months after operation
| Outcome measure | Mean (95% CI) | Effect (95% CI) | |
|---|---|---|---|
| Resurfacing arthroplasty (n=60) | Total hip arthroplasty (n=66) | ||
| Primary | |||
| Harris hip score | 88.4 (84.4 to 92.4) | 82.3 (77.2 to 87.5) | 6.04 (−0.51 to 12.58) |
| Oxford hip score | 40.4 (37.9 to 42.9) | 38.2 (35.3 to 41.0) | 2.23 (−1.52 to 5.98) |
| Secondary | |||
| EQ-5D score | 0.796 (0.721 to 0.870) | 0.719 (0.636 to 0.802) | 0.077 (−0.034 to 0.188) |
| EQ-5D VAS scale | 78.2 (73.9 to 83.4) | 76.2 (70.8 to 81.5) | 2.1 (−5.3 to 9.4) |
| Disability rating index | 27.7 (21.7 to 33.7) | 34.8 (28.4 to 41.2) | −7.1 (−15.8 to 1.6) |
| Paffenbarger activity (mJ/week) | 15.01 (10.15 to 19.87) | 13.85 (10.90 to 17.80) | 1.17 (−4.99 to 7.32) |
VAS=visual analogue health scale.